PortfoliosLab logoPortfoliosLab logo
ED vs. ABBV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ED vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Consolidated Edison, Inc. (ED) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ED achieves a 5.89% return, which is significantly higher than ABBV's -3.41% return. Over the past 10 years, ED has underperformed ABBV with an annualized return of 6.98%, while ABBV has yielded a comparatively higher 17.56% annualized return.


ED

1D
-0.30%
1M
-4.82%
YTD
5.89%
6M
9.04%
1Y
3.56%
3Y*
7.72%
5Y*
9.79%
10Y*
6.98%

ABBV

1D
0.80%
1M
4.31%
YTD
-3.41%
6M
-4.15%
1Y
19.73%
3Y*
20.88%
5Y*
18.44%
10Y*
17.56%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ED vs. ABBV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ED
Consolidated Edison, Inc.
5.89%15.15%1.55%-1.12%15.65%22.96%-16.99%22.54%-6.62%19.30%
ABBV
AbbVie Inc.
-3.41%33.08%18.86%-0.23%24.01%32.43%27.72%1.47%-0.96%60.07%

Correlation

The correlation between ED and ABBV is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.27

Correlation (3Y)
Calculated over the trailing 3-year period

0.29

Correlation (5Y)
Calculated over the trailing 5-year period

0.30

Correlation (10Y)
Calculated over the trailing 10-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Jan 3, 2013

0.21

Fundamentals

Market Cap

ED:

$37.71B

ABBV:

$385.19B

EPS

ED:

$5.94

ABBV:

$2.05

PE Ratio

ED:

17.41

ABBV:

105.79

PS Ratio

ED:

2.18

ABBV:

6.13

PB Ratio

ED:

1.61

ABBV:

14.01

Total Revenue (TTM)

ED:

$17.22B

ABBV:

$62.82B

Gross Profit (TTM)

ED:

$11.62B

ABBV:

$46.15B

EBITDA (TTM)

ED:

$8.47B

ABBV:

$17.96B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ED vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ED
ED Risk / Return Rank: 4545
Overall Rank
ED Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
ED Sortino Ratio Rank: 3939
Sortino Ratio Rank
ED Omega Ratio Rank: 3838
Omega Ratio Rank
ED Calmar Ratio Rank: 4949
Calmar Ratio Rank
ED Martin Ratio Rank: 4949
Martin Ratio Rank

ABBV
ABBV Risk / Return Rank: 6262
Overall Rank
ABBV Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 6060
Sortino Ratio Rank
ABBV Omega Ratio Rank: 5959
Omega Ratio Rank
ABBV Calmar Ratio Rank: 6363
Calmar Ratio Rank
ABBV Martin Ratio Rank: 6363
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ED vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Consolidated Edison, Inc. (ED) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


EDABBVDifference
Sharpe ratioReturn per unit of total volatility

-0.61

Sortino ratioReturn per unit of downside risk

-0.88

Omega ratioGain probability vs. loss probability

1.05

1.16

-0.12

Calmar ratioReturn relative to maximum drawdown

0.37

1.14

-0.77

Martin ratioReturn relative to average drawdown

0.81

2.57

-1.76

ED vs. ABBV - Sharpe Ratio Comparison

The current ED Sharpe Ratio is 0.22, which is lower than the ABBV Sharpe Ratio of 0.83. The chart below compares the historical Sharpe Ratios of ED and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


EDABBVDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.22

0.83

-0.61

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.53

0.81

-0.29

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.33

0.68

-0.35

Sharpe Ratio (All Time)

Calculated using the full available price history

0.36

0.73

-0.37

Drawdowns

ED vs. ABBV - Drawdown Comparison

The maximum ED drawdown since its inception was -78.90%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for ED and ABBV.


Loading charts...

Drawdown Indicators


EDABBVDifference

Max Drawdown

Largest peak-to-trough decline

-78.90%

-45.09%

-33.81%

Max Drawdown (1Y)

Largest decline over 1 year

-9.63%

-17.32%

+7.69%

Max Drawdown (3Y)

Largest decline over 3 years

-17.36%

-20.74%

+3.38%

Max Drawdown (5Y)

Largest decline over 5 years

-22.03%

-21.92%

-0.11%

Max Drawdown (10Y)

Largest decline over 10 years

-30.91%

-45.09%

+14.18%

Current Drawdown

Current decline from peak

-9.63%

-9.04%

-0.59%

Average Drawdown

Average peak-to-trough decline

-13.24%

-10.73%

-2.51%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.43%

7.69%

-3.26%

Volatility

ED vs. ABBV - Volatility Comparison

The current volatility for Consolidated Edison, Inc. (ED) is 5.01%, while AbbVie Inc. (ABBV) has a volatility of 5.42%. This indicates that ED experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EDABBVDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.01%

5.42%

-0.41%

Volatility (6M)

Calculated over the trailing 6-month period

11.85%

17.61%

-5.76%

Volatility (1Y)

Calculated over the trailing 1-year period

16.33%

23.96%

-7.63%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.73%

22.84%

-4.11%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

20.99%

25.74%

-4.75%

Dividends

ED vs. ABBV - Dividend Comparison

ED's dividend yield for the trailing twelve months is around 3.36%, more than ABBV's 3.10% yield.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
3.10%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
ED
Consolidated Edison, Inc.
3.36%3.42%3.72%3.56%3.32%3.63%4.23%3.27%3.74%3.25%3.64%4.05%

Financials

ED vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Consolidated Edison, Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


5.00B10.00B15.00B20222023202420252026
5.10B
15.00B
(ED) Total Revenue
(ABBV) Total Revenue
Values in USD except per share items

ED vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between Consolidated Edison, Inc. and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%55.0%60.0%65.0%70.0%75.0%80.0%85.0%20222023202420252026
81.5%
83.5%
Portfolio components
ED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Consolidated Edison, Inc. reported a gross profit of 4.15B and revenue of 5.10B. Therefore, the gross margin over that period was 81.5%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.

ED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Consolidated Edison, Inc. reported an operating income of 1.18B and revenue of 5.10B, resulting in an operating margin of 23.1%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.

ED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Consolidated Edison, Inc. reported a net income of 924.00M and revenue of 5.10B, resulting in a net margin of 18.1%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.


Frequently Asked Questions


ED and ABBV have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ABBV has higher volatility (5.42%) compared to ED (5.01%). In terms of maximum drawdown, ED dropped -78.90% vs ABBV's -45.09%.

ABBV currently has the higher Sharpe Ratio (0.83 vs 0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ED and ABBV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer